A Novel Endoglin Variant in Pancreatic Ductal Adenocarcinoma

被引：0
|
作者：
Kumar, Sanjay [1 ]
Shah, Nirav [1 ]
Zaman, Naveed [1 ]
Lee, Nam Y. [1 ]
机构：
[1] Ohio State Univ, Coll Pharm, 500 W 12Th Ave, Columbus, OH 43210 USA
来源：
FASEB JOURNAL | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
934.22
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma
    McGowan, Ryan
    Sally, Aine
    McCabe, Anthony
    Moran, Brian Michael
    Finn, Karen
    CANCERS, 2022, 14 (08)
  • [22] Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma
    Gao, Yasheen
    Wang, Melinda
    Guo, Xiaojia
    Hu, Joanna
    Chen, Tian-min
    Finn, Sade M. B.
    Lacy, Jill
    Kunstman, John W.
    Cha, Charles H.
    Bellin, Melena D.
    Robert, Marie E.
    Desir, Gary, V
    Gorelick, Fred S.
    PLOS ONE, 2021, 16 (09):
  • [23] A novel hedgehog signaling inhibitor for targeting pancreatic ductal adenocarcinoma
    Khire, Atul
    Zhong, Yi
    Rajanala, Kalpana
    Iacobuzio-Donahue, Christine
    Resh, Marilyn D.
    CANCER RESEARCH, 2019, 79 (13)
  • [24] Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia
    Bhanot, Umesh K.
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2008, 7 (01) : 106 - 107
  • [25] MicroRNAs: Novel Diagnostic and Therapeutic Tools for Pancreatic Ductal Adenocarcinoma?
    Mardin, Wolf Arif
    Mees, Soeren Torge
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (11) : 3183 - 3189
  • [26] Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma
    Luo, Yanli
    Qiu, Zhengjun
    Tian, Ling
    Zhu, Guanghui
    Feng, Ye
    Yi, Miaoying
    Chen, Xiafang
    Wang, Liwei
    Li, Chuanyuan
    Huang, Qian
    HUMAN PATHOLOGY, 2013, 44 (01) : 69 - 76
  • [27] Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
    Demir, Tarik
    Moloney, Carolyn
    Mahalingam, Devalingam
    CANCERS, 2025, 17 (05)
  • [28] Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma
    Fischietti, Mariafausta
    Eckerdt, Frank
    Blyth, Gavin T.
    Arslan, Ahmet D.
    Mati, William M.
    Oku, Chidera, V
    Perez, Ricardo E.
    Lee-Chang, Catalina
    Kosciuczuk, Ewa M.
    Saleiro, Diana
    Beauchamp, Elspeth M.
    Lesniak, Maciej S.
    Verzella, Daniela
    Sun, Leyu
    Fish, Eleanor N.
    Yang, Guang-Yu
    Qiang, Wenan
    Platanias, Leonidas C.
    ONCOGENE, 2021, 40 (18) : 3273 - 3286
  • [29] Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma
    Q. Li
    S. H. Maier
    P. Li
    J. Peterhansl
    C. Belka
    J. Mayerle
    U. M. Mahajan
    Radiation Oncology, 15
  • [30] TRAILshort is a Novel Potential Therapeutic Target in Pancreatic Ductal Adenocarcinoma
    Khandakar, Binny
    Chandrasekar, Aswath P.
    Krogman, Ashton
    VanTreeck, Benjamin
    Cummins, Nathan
    Natesampillai, Sekar
    Garcia-Rivera, Enrique
    Rathore, Mahendra
    Khazaie, Khashayarsha
    Badley, Andrew
    Graham, Rondell
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 1049 - 1049
12345